The damage of the protective covering (myelin sheath) that surrounds nerve fibers in brain, optic nerves and spinal cord leads to development of demyelinating disorders. The damaged myelin sheath makes the nerve impulses slow or even stop, causing neurological problems. Demyelination causes neurological deficits, such as vision changes, weakness, altered sensation, and behavioral or cognitive problems. Demyelination can occur at any age.
Symptoms of demyelinating diseases include
Loss of vision
Numbness or tingling of upper or lower limbs
Weakness of the arms or legs
Poor coordination/gait problem
Difficulty in swallowing
Deceased bowel or bladder control
Mood or behavioral changes
Genetic mutations, infectious agents, autoimmune reactions, Vitamin B12 deficiency and other unknown factors results in dysmyelination.
Market Analysis: In the forecast period of 2020 to 2027, the global market for demyelinating disorders treatments is expected to increase. The myelin sheath, a protective layer that surrounds nerve fibres in the brain, optic nerves, and spinal cord, is damaged in demyelinating illnesses. The market for demyelinating disorders therapies is divided into immunomodulators, immunosuppressants, interferons, and others based on medication class. The market for demyelinating disorders therapies is divided into two segments: oral and parenteral. he demyelinating disorders therapeutics market is divided into hospitals, homecare, specialty clinics, and others based on end users. The market for demyelinating disorders therapeutics has been divided into three categories based on distribution channels: hospital pharmacy, online pharmacy, and retail pharmacy.
ALSO READ Neurology Neurosurgery Neuroscience Neuropsychiatry Pain Disorder and Management Central Nervous System Pediatric Neurology Neuro-Oncology and Brain Tumors Neurophysiology Neuroimmunology Neuropathology Neuroimaging Neurodegenerative disease and Neurodegeneration Neurological Disorders Sleep Disorder Stroke Movement Disorders Parkinsons disease Epilepsy Multiple Sclerosis Alzheimers Disease and Dementia Neuromuscular Disease Case studies and Clinical trials Novel Treatment Strategies Speech Disorders Demyelinating Disorders Cerebrovascular Disorders Autoimmune and Inflammatory Disorders Neuropathy Headache and Facial Pain Diagnosis and Screening of Neurological Disorders Neurology Critical Care Neuropharmacology and Neurochemistry Stem Cells and Neuroregeneration Cognitive Neuroscience Motor System Disorders
Sleep Disorders Conferences Epilepsy Conferences Neurology Conferences 2022 USA Alzheimer's Disease Conferences Neurology Conferences 2022 Japan Psychology Conferences Neurology Conferences 2022 Neurodegenerative Disorders Conferences Euro Neurology Conferences Stroke Conferences Neurology Conferences 2022 Neurology Conferences USA Parkinson Disease Conferences Headache Conferences Neurosurgery Conferences